Christopher M Loughrey

6PUBLICATIONS
35CO-AUTHORS
Respiratory diseasesCardiology (incl. cardiovascular diseases)Molecular medicineGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 26, 2026
Targeting RUNX1 protects against diastolic dysfunction in a two-hit mouse model of heart failure with preserved ejection fraction.

|Apr 11, 2025
The Heart Has Intrinsic Ketogenic Capacity that Mediates NAD+ Therapy in HFpEF.

Yen Chin Koay, Bailey McIntosh, Yann Huey Ng

|May 21, 2024
A novel ryanodine receptor 2 inhibitor, M201-A, enhances natriuresis, renal function and lusi-inotropic actions: Preclinical and phase I study.

Noboru Kaneko, Christopher M Loughrey, Godfrey Smith

|Jul 11, 2023
Ribonucleicacid interference or small molecule inhibition of Runx1 in the border zone prevents cardiac contractile dysfunction following myocardial infarction.

Tamara P Martin, Eilidh A MacDonald, Ashley Bradley

|Jun 16, 2021
Inhibition of myocardial cathepsin-L release during reperfusion following myocardial infarction improves cardiac function and reduces infarct size.

Weihong He, Charlotte S McCarroll, Katrin Nather

|Jun 16, 2021
Preclinical models of myocardial infarction: from mechanism to translation.

Tamara P Martin, Eilidh A MacDonald, Ali Ali Mohamed Elbassioni

Pageof 1

Frequent Collaborators

4 joint publications

Eilidh A MacDonald

3 joint publications

Colin Berry

2 joint publications

Tamara P Martin

2 joint publications

Stuart A Nicklin